Skip to main content
SpringerLink
Log in

The FORTA (Fit fOR The Aged) List 2015: Update of a Validated Clinical Tool for Improved Pharmacotherapy in the Elderly

  • Letter to the Editor
  • Published:
Drugs & Aging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone Survey. JAMA. 2002;287:337–44.

    Article  PubMed  Google Scholar 

  2. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;2015(63):2227–46.

    Article  Google Scholar 

  3. Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the Priscus list. Dtsch Ärztebl Int. 2010;107:543–51.

    PubMed  PubMed Central  Google Scholar 

  4. Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015;71:1415–27.

    Article  PubMed  Google Scholar 

  5. Hanlon JT, Semla TP, Schmader KE. Alternative medications for medications in the use of high-risk medications in the elderly and potentially harmful drug–disease interactions in the elderly quality measures. J Am Geriatr Soc. 2015;63:e8–18.

    Article  PubMed  Google Scholar 

  6. Kuhn-Thiel AM, Weiss C, Wehling M, The FORTA Authors/Expert Panel Members. Consensus validation of the FORTA (Fit fOR The Aged) list: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly. Drugs Aging. 2014;31:131–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Wehling M. Multimorbidity and polypharmacy: how to reduce the harmful drug load and yet add needed drugs in the elderly? Proposal of a new drug classification: Fit fOR The Aged. J Am Geriatr Soc. 2009;57:560–1.

    Article  PubMed  Google Scholar 

  8. Barry PJ, Gallagher P, Ryan C, O’Mahony D. START—an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing. 2007;36:632–8.

    Article  CAS  PubMed  Google Scholar 

  9. Michalek C, Wehling M, Schlitzer J, Frohnhofen H. Effects of “Fit fOR The Aged” (FORTA) on pharmacotherapy and clinical endpoints—a pilot randomized controlled study. Eur J Clin Pharmacol. 2014;70:1261–7.

    Article  CAS  PubMed  Google Scholar 

  10. Wehling M, Burkhardt H, Kuhn-Thiel AM, Pazan F, Throm C, Weiss C, Frohnhofen H. VALFORTA—a randomized trial to validate the FORTA (“Fit fOR The Aged”) classification. Age Ageing. 2016;45(2):262–7. doi:10.1093/ageing/afv200.

    Article  PubMed  Google Scholar 

  11. Wehling M. How to use the FORTA (“Fit fOR The Aged”) list to improve pharmacotherapy in the elderly. Drug Res. 2016;66:57–62.

    CAS  Google Scholar 

Download references

Acknowledgments

FORTA List Initiators and Their Affiliations

Martin Wehling, MD; Center for Geriatric Pharmacology, Institute of Experimental and Clinical Pharmacology, University of Heidelberg, Maybachstrasse 14, 68169 Mannheim, Germany

Heinrich Burkhardt, MD; Geriatric Medicine, 4th Department of Medicine, University Medical Centre Mannheim, Theodor-Kutzer-Ufer 1–3, 68167 Mannheim, Germany

Stefan Schwarz, MD; Central Institute of Mental Health, J5, 68159 Mannheim, Germany

Ulrich Wedding, MD; Clinic for Internal Medicine II, University Hospital, Bachstrasse 18, 07743 Jena, Germany

Expert Panel Members (Raters) and Their Affiliations

Jürgen Bauer, MD; Geriatrics Centre Oldenburg, University of Oldenburg, Rahel-Straus-Strasse 10, 26133 Oldenburg, Germany

Heiner K. Berthold, MD; Department of Internal Medicine and Geriatrics, Bielefeld Evangelical Hospital (EvKB), Schildescher Strasse 99, 33611 Bielefeld, Germany

Michael Denkinger, MD; AGAPLESION Bethesda Klinik Ulm, University Hospital Ulm, Zollernring 26, 89073 Ulm, Germany

Peter Dovjak, MD; Department of Acute Geriatric Medicine, Gmunden Hospital, Miller-von-Aichholz-Strasse 49, 4810 Gmunden, Austria

Helmut Frohnhofen, MD; Essen-Mitte Hospital, Knappschafts Hospital, Teaching Hospital at the University of Duisburg in Essen, Am Deimelsberg 34a, 45276 Essen, Germany; and Faculty of Health, University of Witten-Herdecke, Witten, Germany

Thomas Frühwald, MD; Geriatric Department, Hietzing Hospital, Wolkersbergenstrasse 1, 1130 Vienna, Austria

Christoph Gisinger, MD; Haus der Barmherzigkeit, Danube University Krems, Seeböckgasse 30a, 1160 Vienna, Austria

Manfred Gogol, MD; Geriatric Department, Lindenbrunn Hospital, Lindenbrunn 1, 31863 Coppenbruegge, Germany

Markus Gosch, MD; Medical Clinic 2, Geriatric Department, University Hospital of the Paracelsus Medical University, Nürnberg Hospital North, Prof.-Ernst-Nathan-Strasse 1, 90419 Nürnberg, Germany

Hans Gutzmann, MD; Clinic for Psychiatry, Psychotherapy and Psychosomatic Medicine, Hedwigshöhe Hospital, Höhensteig 1, 12526 Berlin, Germany

Isabella Heuser, MD; Department of Psychiatry and Psychotherapy, Charité University Hospital Berlin, University Medicine Berlin, Campus Benjamin Franklin, Eschenallee 3, 14050 Berlin, Germany

Michael Hüll, MD; Center for Geriatric Medicine and Gerontology Freiburg, University Clinic Freiburg, Lehener Strasse 88, 79106 Freiburg, Germany

Bernhard Iglseder, MD; Department of Geriatric Medicine, Christian-Doppler-Klinik, Paracelsus Medical University, Ignaz-Harrer-Strasse 79, 5020 Salzburg, Austria

Siegfried Kasper, MD; Department of Psychiatry and Psychotherapy, Medical University of Vienna, AKH, Währinger Gürtel 18–20, 1090 Vienna, Austria

Anja Kwetkat, MD; Department of Geriatric Medicine, Jena University Hospital, Bachstrasse 18, 07740 Jena, Germany

Wolfgang von Renteln-Kruse, MD; Albertinen Hospital/Albertinen House nonprofit company (GmbH), Center for Geriatric Medicine and Gerontology, Scientific Institution at the University of Hamburg, Sellhopsweg 18–22, 22459 Hamburg, Germany

Christoph Schindler, MD; CRC-MHH Core Facility, Clinical Research Center Hannover, Feodor-Lynen-Strasse 15, 30625 Hannover, Germany

Matthias Schuler, MD; Diakonissenkrankenhaus Mannheim, Speyerer Strasse 91–93, 68163 Mannheim, Germany

Ralf-Joachim Schulz, MD; Geriatric Clinic at the St.-Marien Hospital, Kunibertkloster 11–13, 50668 Köln, Germany

Ulrike Sommeregger, MD; Hietzing Hospital and Neurological Center Rosenhügel, Wolkersbergenstrasse 1, 1130 Vienna, Austria

Andrej Zeyfang, MD; University of Ulm, Institute of Epidemiology and Medical Biometry, Albert-Einstein-Allee 41, 89081 Ulm, Germany; AGAPLESION Bethesda Krankenhaus Stuttgart, Hohenheimer Strasse 21, 70184 Stuttgart, Germany

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, Center for Geriatric Pharmacology in Mannheim at the University of Heidelberg, Mannheim, Germany

    Farhad Pazan & Martin Wehling

  2. Department of Medical Statistics, Biomathematics and Information Processing, Medical Faculty Mannheim at the University of Heidelberg, Mannheim, Germany

    Christel Weiss

Authors
  1. Farhad Pazan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christel Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Wehling
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

FORTA

Corresponding author

Correspondence to Martin Wehling.

Ethics declarations

Martin Wehling was employed by AstraZeneca R&D (Mölndal, Sweden) as the Director of Discovery Medicine [=Translational Medicine] from 2004 to 2006 while on sabbatical leave from his professorship at the University of Heidelberg. Since returning to this position in January 2007, he has received lecturing and consulting fees from Sanofi-Aventis, Bayer, Boehringer Ingelheim, Novartis, Takeda, Roche, Pfizer, Bristol-Myers Squibb, Daichii-Sankyo, Lilly, LEO Pharma, Novo-Nordisk, Shire and Pro Bono Bio Entrepreneur Ltd. Farhad Pazan and Christel Weiss have no conflicts of interest that are directly relevant to the content of this letter.

Additional information

The complete list of “FORTA” members are listed in the Acknowledgments section.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pazan, F., Weiss, C., Wehling, M. et al. The FORTA (Fit fOR The Aged) List 2015: Update of a Validated Clinical Tool for Improved Pharmacotherapy in the Elderly. Drugs Aging 33, 447–449 (2016). https://doi.org/10.1007/s40266-016-0371-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-016-0371-4

Keywords

Search

Navigation